TUESDAY, Aug. 19, 2014 (HealthDay News) -- Newborn screening programs in the United States have identified severe combined immunodeficiency (SCID) in one in 58,000, with high survival seen in SCID-affected infants, according to a study published in the Aug. 20 issue of the Journal of the American Medical Association.
Antonia Kwan, Ph.D., from the University of California in San Francisco, and colleagues presented data from a spectrum of SCID newborn screening programs to establish the population-based incidence of SCID. Data were submitted for 3,030,083 newborns from 10 states, screened with assays to detect T-c...
Also read: Want to Make Budget Cuts? Start Here